<p>Columns represent the assays, the target parameter names, the estimated parameter value, the standard error of the parameter estimate, the confidence intervals and the associated p-value for testing the significance of the parameter to the model. P-values less than 0.05 are considered significant (*). The estimator is a parameter that indicates the average value, on which the head and neck cancer patients have less or greater values compared to breast cancer patients.</p
Primary chemotherapy represents an ideal model to evaluate the relationships between treatments and ...
<p>Comparison of ADC values from Breast Tissue, Malignant Breast Lesions, Metastatic LNs and Diagnos...
<p>CI, confidence interval; HR, hazard ratio. Note: Unadjusted HR and 95% CI were obtained from a Co...
*<p>P-value<0.05 is significant.</p>**<p>P-value assesses significance within the column. (P<0.05 is...
Aims-To compare the two breast tumour markers, CA15-3 and mucinous-like carcinoma associated antigen...
<p>Abbreviations: N = number; SE = standard error.</p>a.<p>P-values were calculated using chi-squ...
BACKGROUND: Normal-tissue complication probability (NTCP) models predict complication risk in patien...
<p><b>Abbreviations</b>: MyD88, myeloid differentiation primary response 88; TLR4, Toll-like recepto...
Trial results are usually given in terms of end point confidence intervals, the data concerning the ...
<p>TNM tumor-node-metastasis, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal g...
<p>The y-axis of left column of the each of the two figures represents fold changes of the gene expr...
<p>Quantitative comparison of (A) VV and (B) PS for hypoxic and normoxic breast tumor regions. Colum...
Comparison of epidemiological and clinicopathological parameters between familial and sporadic breas...
Aims: There has been a resurgence in interest in radiobiological modelling in head and neck cancer. ...
The major end-points arising from cancer clinical trials are reviewed. These are: tumour response, t...
Primary chemotherapy represents an ideal model to evaluate the relationships between treatments and ...
<p>Comparison of ADC values from Breast Tissue, Malignant Breast Lesions, Metastatic LNs and Diagnos...
<p>CI, confidence interval; HR, hazard ratio. Note: Unadjusted HR and 95% CI were obtained from a Co...
*<p>P-value<0.05 is significant.</p>**<p>P-value assesses significance within the column. (P<0.05 is...
Aims-To compare the two breast tumour markers, CA15-3 and mucinous-like carcinoma associated antigen...
<p>Abbreviations: N = number; SE = standard error.</p>a.<p>P-values were calculated using chi-squ...
BACKGROUND: Normal-tissue complication probability (NTCP) models predict complication risk in patien...
<p><b>Abbreviations</b>: MyD88, myeloid differentiation primary response 88; TLR4, Toll-like recepto...
Trial results are usually given in terms of end point confidence intervals, the data concerning the ...
<p>TNM tumor-node-metastasis, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal g...
<p>The y-axis of left column of the each of the two figures represents fold changes of the gene expr...
<p>Quantitative comparison of (A) VV and (B) PS for hypoxic and normoxic breast tumor regions. Colum...
Comparison of epidemiological and clinicopathological parameters between familial and sporadic breas...
Aims: There has been a resurgence in interest in radiobiological modelling in head and neck cancer. ...
The major end-points arising from cancer clinical trials are reviewed. These are: tumour response, t...
Primary chemotherapy represents an ideal model to evaluate the relationships between treatments and ...
<p>Comparison of ADC values from Breast Tissue, Malignant Breast Lesions, Metastatic LNs and Diagnos...
<p>CI, confidence interval; HR, hazard ratio. Note: Unadjusted HR and 95% CI were obtained from a Co...